News

GHTC delivers statement on global strategy on health, innovation, and IP at WHO Executive Board meeting

GHTC delivered a statement at the 148th session of the World Health Organization (WHO) Executive Board calling on WHO to address leading barriers to innovation of and access to essential health products. The statement, issued through the Global Health Council, urges WHO and member states to bolster regulatory capacity and harmonization, strengthen the Global Observatory on Health Research and Development, develop target product profiles for needed tools, and expand the Essential Diagnostics List as part of this effort.

Learn more

GHTC joins GHC in WHA statement on UHC and other health challenges

As a member of the Global Health Council's (GHC) delegation for the second session of the 73rd World Health Assembly (WHA), GHTC joined GHC in its statement from civil society urging continued investments in R&D to achieve universal health coverage (UHC), advance immunization coverage through the Global Vaccine Action Plan, and close the US$1.3 billion funding gap for tuberculosis R&D.

Learn more

GHTC joins GHC statement to WHO EB on COVID-19 response

GHTC joined a civil society statement from the Global Health Council—in response to the special session of the World Health Organization (WHO) Executive Board (EB)—imploring WHO member states to take urgent action to accelerate the development and equitable global delivery of COVID-19 technologies.

PDF

GHTC joins GHC in urging US funding for international COVID-19 response

GHTC endorsed a Global Health Council letter urging Congress to allocate at least US$20 billion in emergency supplemental funding for programs funded through the International Affairs Budget, including at least $11 billion for bilateral global health programs and the multilateral response to support a holistic global response to COVID-19.

PDF

GHTC endorses call to action outlining recommendations to G20 Health and Finance Ministers

GHTC has joined partners to issue a call to action through the G20 Health and Development partnership, urging leaders to fully fund the Access to COVID-19 Tools Accelerator, commit to greater investment and focus on antimicrobial resistance, incentivize sustainable funding models for capacity-building and preparedness, and recognize and act upon the recommendations from the Global Preparedness Monitoring Board and the Independent Panel for Pandemic Preparedness and Response. 

PDF

GHTC sends FY22 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2022 (FY22) budget.

PDF

GHTC joins letter urging Congress to maintain WHO membership and funding

GHTC joined a scientific community letter to Congressional leaders urging Congress do do everything possible to maintain the United States' membership and funding for the World Health Organization (WHO).

PDF

GHTC provides input on Senate pandemic preparedness legislation

GHTC submitted feedback on white paper released by Senator Lamar Alexander (R-TN), chair of the Senate Health, Education, Labor and Pensions Committee, outlining proposals to shape pandemic preparedness legislation to be considered by the committee this year. GHTC provided a number of policy recommendations to strengthen the health R&D ecosystem, including improving coordination between R&D agencies and increasing funding for R&D for naturally-occurring threats at the Biomedical Advanced Research and Development Authority.

PDF